Successfully executing on upcoming digital transformation initiatives has as much to do with effectively managing risk as it does with keeping up with the development of latest industry trends. No company wants to go all-in on the latest trend only to watch it be short-lived or unsustainable. A good example of this fear might be the latest dip in cryptocurrency values. While blockchain technology does seem to have real potential – it is still entirely too new and untested for the majority of organizations to commit significant resources to it. At the same time, being too slow to adapt can spell disaster for even the well-established organizations. Empty Blockbuster, Radio Shack and, soon, Toys R Us stores stand as daily reminders that standing in the way of change means only that you’re waiting to get run over by it.Continue Reading
The Internet of Medical Things (IoMT) refers to the collection of medical devices and applications that communicate to healthcare IT systems through networking technologies. This is part of the wider movement happening in manufacturing, smart homes, energy management and smart cities also known as IoT (Internet of Things). Digital health is rising as consumers are taking more responsibility for their health and are demanding better access to their medical data, with technology organizations and startups finding easier ways to extracting this data and turn it into meaningful insights.Continue Reading
In our recent blog, 3 Issues Facing Discrete Manufacturers in Industry 4.0 , we mentioned the importance of high levels of visibility throughout the production process. This topic is being brought up more and more as manufacturers push to capture staggering amounts of data in order to gain a competitive advantage over the rest of the industry.
FDA regulated organizations have a lot of challenges that can and should be turned into opportunities. Have you ever asked yourself if you have the necessary IT infrastructure that allows your business to identify opportunities for growth? Today, in the highly competitive Life Sciences and Food & Beverage industries, remaining compliant while optimizing your manufacturing process to meet the demand is a tough challenge.
Investing in the right people, processes and technology can enable you to effectively sidestep some of the challenges while keeping you focused on the long-term goal.
So how can FDA regulated organizations use technology to manage the challenges in this complex and ever-changing environment?
On top of the common challenges facing manufacturers in the wake of the digitalization of the industry, discrete manufacturers face added layers of complexity due to the specific nature of their organizations. The market segment in which these organizations operate is characterized by volatile markets that are subject to sweeping technological changes and short product lifespans. This forces discrete manufacturers and in particular lean manufacturers to have high visibility and control over the entirety of the production process in order to remain flexible and quickly adapt to unforeseen market shifts.